Jesse Goodman

News / Photos

Quotes

1 of 2

HOUSE HEARING ON FLU VACCINE

Centers for Disease Control and Prevention director Dr. Julie Gerberding and and Food and Drug Administration Center for Biologics Evaluation and Research Director Dr. Jesse Goodman give testimony during a House Committee on Government Reform hearing on Thursday, Feb. 10, 2005, in Washington. Gerberding gave an update about the status of flu vaccines. (UPI Photo/Kamenko Pajic)

License photo

Enlarge

UPI Related News

FDA approves four H1N1 vaccines

WASHINGTON, Sept. 15 (UPI) -- The U.S. Food and Drug Administration announced approval Tuesday of four vaccines to be used against the H1N1 influenza virus, also called swine flu.

RiaSTAP OK'd for genetic bleeding defect

WASHINGTON, Jan. 20 (UPI) -- The U.S. Food and Drug Administration has approved RiaSTAP for the treatment of bleeding in patients with a rare genetic defect.

Hereditary angioedema drug is approved

WASHINGTON, Oct. 13 (UPI) -- The U.S. Food and Drug Administration has approved for marketing the first product in the United States that protects people with hereditary angioedema.

FDA approves hemophilia A drug

WASHINGTON, Oct. 13 (UPI) -- The U.S. Food and Drug Administration has approved a new use for the blood product Kogenate FS in children with the most severe form of hemophilia.

FDA works to create safe malaria vaccines

WASHINGTON, Oct. 7 (UPI) -- The U.S. Food and Drug Administration said it is entering into a collaboration to create better safety and efficacy tests for experimental malaria vaccines.

FDA OKs new adhesive to treat burn victims

WASHINGTON, March 20 (UPI) -- The U.S. Food and Drug Administration approved a medical adhesive -- a fibrin sealant called Artiss -- for use in attaching skin grafts to burn patients.

FDA approves new hemophilia treatment

WASHINGTON, Feb. 21 (UPI) -- The U.S. Food and Drug Administration approved a new treatment for hemophilia A -- a rare, hereditary blood-clotting disorder.

FDA OKs novel surgical clotting solution

WASHINGTON, Jan. 17 (UPI) -- The U.S. Food and Drug Administration announced approval Thursday of the first clotting solution made using recombinant DNA techniques.

FDA expands use of bleeding sealant

WASHINGTON, Jan. 16 (UPI) -- The U.S. Food and Drug Administration has expanded use of a liquid protein sealant to help control bleeding during general surgery.

FDA approves blood typing tests

WASHINGTON, Jan. 14 (UPI) -- The U.S. Food and Drug Administration has licensed 14 new tests for determining a person's blood type.

1 of 3 Prev | Next

Related Topics